The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study
Fenoldopam for controlled hypotension during spinal fusion in children and adolescents
Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises
Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study
Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies
DA1-receptor stimulation by fenoldopam in the treatment of postcardiac surgical hypertension
Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies
Potential of dopamine A-1 agonists in the management of acute renal failure
Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status
Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status
Effects of dopaminergic drugs on the sympathoadrenal system
Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension
A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery
